Viewing Study NCT06994195


Ignite Creation Date: 2025-12-24 @ 2:00 PM
Ignite Modification Date: 2026-01-23 @ 12:54 PM
Study NCT ID: NCT06994195
Status: RECRUITING
Last Update Posted: 2025-08-17
First Post: 2025-05-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epithelial Ovarian Cancer View
None Fallopian Tube Cancer View
None Primary Peritoneal Cancer View
Keywords: